Aarsh Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.00 M
as on 17-11-2024
- Revenue -4.80%
(FY 2023)
- Profit -18.83%
(FY 2023)
- Ebitda -75.62%
(FY 2023)
- Net Worth 16.79%
(FY 2023)
- Total Assets -2.10%
(FY 2023)
About Aarsh Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹4.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ajaykumar Sheth and Anuradhaben Sheth serve as directors at the Company.
- CIN/LLPIN
U24230GJ2010PTC059782
- Company No.
059782
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aarsh Remedies Private Limited offer?
Aarsh Remedies Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Vitamin Tablets & Capsules, Vitamin A Tablet & Capsules, Pharmaceutical Tablets, Anti Inflammatory Drugs, Aceclofenac Tablet, Aceclofenac Paracetamol Tablet, Mineral Supplement, Calcium Tablet.
Who are the key members and board of directors at Aarsh Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajaykumar Sheth  | Director | 06-Mar-2010 | Current |
| Anuradhaben Sheth | Director | 06-Mar-2010 | Current |
Financial Performance of Aarsh Remedies.
Aarsh Remedies Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.8% decrease. The company also saw a substantial fall in profitability, with a 18.83% decrease in profit. The company's net worth Soared by an impressive increase of 16.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aarsh Remedies?
In 2023, Aarsh Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 29 Oct 2010 | ₹4.00 M | Satisfied |
How Many Employees Work at Aarsh Remedies?
Aarsh Remedies has a workforce of 24 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarsh Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarsh Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
